• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Ocugen, Inc.

Monday, June 03, 2024
CP
Cell and Gene Therapy and Genome Editing
Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines that improve health and offer hope for patients across the globe. We are making an impact on patients’ lives through courageous innovation—forging new scientific paths that harness our unique intellectual and human capital. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with a single product, and we are advancing research in infectious diseases to support public health and orthopedic diseases to address unmet medical needs.
Ocugen, Inc.
Company Website: http://www.ocugen.com
Lead Product in Development: OCU400

Exchange

Nasdaq

Ticker

OCGN

Company HQ City

Malvern

Company HQ State

PA

Company HQ Country

United States

CEO/Top Company Official

Shankar Musunuri

Development Phase of Primary Product

Phase III
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS